Correction: Effectiveness of a multicomponent quality improvement strategy to improve achievement of diabetes care goals (Annals of Internal Medicine (2016) 165 (399-408) DOI: 10.7326/M15-2807);Effectiveness of a multicomponent quality improvement strategy to improve achievement of diabetes care goals a randomized, controlled trial

Annals of Internal Medicine

Volumn 165, Issue 6, 2016, Pages 399-408

  Ali, Mohammed K ^a   Singh, Kavita ^b   Kondal, Dimple ^c   Devarajan, Raji ^c   Patel, Shivani A ^a   Shivashankar, Roopa ^c   Ajay, Vamadevan S ^c   Unnikrishnan, A G ^d   Usha Menon, V ^e   Varthakavi, Premlata K ^f   Viswanathan, Vijay ^g   Dharmalingam, Mala ^h   Bantwal, Ganapati ⁱ   Sahay, Rakesh Kumar ^j   Masood, Muhammad Qamar ^k   Khadgawat, Rajesh ^b   Desai, Ankush ^l   Sethi, Bipin ^m   Prabhakaran, Dorairaj ^c   Venkat Narayan, K M ^a   Tandon, Nikhil ^b   more..

^a EMORY UNIVERSITY   (United States)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^d Chellaram Diabetes Institute   (India)

^e AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^f BYL NAIR CHARITABLE HOSPITAL   (India)

^g MV Hospital for Diabetes   (India)

^h Bangalore Endocrinology and Diabetes Research Center   (India)

ⁱ ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^j OSMANIA GENERAL HOSPITAL   (India)

^k AGA KHAN UNIVERSITY   (Pakistan)

^l GOA MEDICAL COLLEGE   (India)

^m CARE HOSPITAL   (India)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DIABETES MELLITUS; DISEASE DURATION; ELECTRONIC HEALTH RECORD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TOTAL QUALITY MANAGEMENT; BLOOD; BLOOD PRESSURE; CLINICAL DECISION SUPPORT SYSTEM; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; FOLLOW UP; INDIA; METABOLISM; PAKISTAN; STANDARDS; TREATMENT OUTCOME;

BLOOD PRESSURE; CHOLESTEROL, LDL; DECISION SUPPORT SYSTEMS, CLINICAL; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORDS; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INDIA; MALE; MIDDLE AGED; PAKISTAN; PATIENT CARE TEAM; QUALITY IMPROVEMENT; QUALITY OF LIFE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84988462522     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/L17-0327     Document Type: Erratum

References (47)

1. International Diabetes Federation Web site. Accessed at www.idf .org/diabetesatlas on 10 June 2016.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-53. [PMID: 9742976]
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86. [PMID: 8366922]
4. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353:2643-53. [PMID: 16371630]
5. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-89. [PMID: 18784090] doi:10.1056 /NEJMoa0806470
6. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-13. [PMID: 9732337]
7. Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al; ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet. 2007;370:829-40. [PMID: 17765963]
8. Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, et al; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005;165:1410-9. [PMID: 15983291]
9. Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet. 2003;361:2005-16. [PMID: 12814710]
10. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective metaanalysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-78. [PMID: 16214597]
11. Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest. 2007; 131:446-52. [PMID: 17296646]
12. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: A systematic review. JAMA. 2003;290:86-97. [PMID: 12837716]
13. American Diabetes Association. 8. Cardiovascular disease and risk management. Diabetes Care. 2016;39 Suppl 1:S60-71. [PMID: 26696684] doi:10.2337/dc16-S011
14. American Diabetes Association. 3. Foundations of care and comprehensive medical evaluation. Diabetes Care. 2016;39 Suppl 1:S23-
15. [PMID: 26696676] doi:10.2337/dc16-S006
16. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-93. [PMID: 12556541]
17. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580-91. [PMID: 18256393] doi:10.1056 /NEJMoa0706245
18. Stone MA, Charpentier G, Doggen K, Kuss O, Lindblad U, Kellner C, et al; GUIDANCE Study Group. Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study. Diabetes Care. 2013;36:2628-38. [PMID: 23628621] doi:10.2337/dc12-1759
19. Zabetian A, Keli HM, Echouffo-Tcheugui JB, Narayan KM, Ali MK. Diabetes in the Middle East and North Africa. Diabetes Res Clin Pract.2013;101:106-22.[PMID:23642969]doi:10.1016/j.diabres.2013 .03.010
20. Ali MK, Bullard KM, Gregg EW, Del Rio C. A cascade of care for diabetes in the United States: visualizing the gaps. Ann Intern Med. 2014;161:681-9. [PMID: 25402511] doi:10.7326/M14-0019
21. Mudaliar U, Kim WC, Kirk K, Rouse C, Narayan KM, Ali M. Are recommended standards for diabetes care met in Central and South America? A systematic review. Diabetes Res Clin Pract. 2013;100: 306-29. [PMID: 23375230] doi:10.1016/j.diabres.2013.01.010
22. Shivashankar R, Kirk K, Kim WC, Rouse C, Tandon N, Narayan KM, et al. Quality of diabetes care in low- and middle-income Asian and Middle Eastern countries (1993-2012): 20-year systematic review. Diabetes Res Clin Pract. 2015;107:203-23. [PMID: 25529849] doi:10.1016/j.diabres.2014.11.004
23. Kerr EA, Gerzoff RB, Krein SL, Selby JV, Piette JD, Curb JD, et al. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: The TRIAD study. Ann Intern Med. 2004; 141:272-81. [PMID: 15313743] doi:10.7326/0003-4819-141-4 -200408170-00007
24. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: A systematic review. Diabetes Care. 2001;24:1821-33. [PMID: 11574449]
25. Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: A meta-regression analysis. JAMA. 2006;296:427-40. [PMID: 16868301]
26. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013;368:1613-24. [PMID: 23614587] doi:10.1056/NEJMsa1213829
27. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370:1514-23. [PMID: 24738668] doi:10.1056/NEJMoa1310799
28. Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, et al. Effectiveness of quality improvement strategies on the management of diabetes: A systematic review and meta-analysis. Lancet. 2012;379:2252-61. [PMID: 22683130] doi:10.1016/S0140-6736(12) 60480-2
29. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care. 2004;27:1535-40. [PMID: 15220224]
30. Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23:588-94. [PMID: 18317847] doi:10.1007/s11606-008-0554-8
31. Shah S, Singh K, Ali MK, Mohan V, Kadir MM, Unnikrishnan AG, et al; CARRS Trial Writing Group. Improving diabetes care: multicomponent cardiovascular disease risk reduction strategies for people with diabetes in South Asia-the CARRS multi-center translation trial. Diabetes Res Clin Pract. 2012;98:285-94. [PMID: 23084280] doi: 10.1016/j.diabres.2012.09.023
32. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33 Suppl 1:S11-61. [PMID: 20042772] doi:10.2337/dc10-S011
33. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229-32. [PMID: 1524068]
34. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2013.
35. Little RJA. A test of missing completely at random for multivariate data with missing values. J Am Stat Assoc. 1988;83:1198-202.
36. Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22:278-95. [PMID: 21220355] doi:10.1177/0962280210395740
37. Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res. 2011;20:40-9. [PMID: 21499542] doi:10.1002/mpr .329
38. Marchenko YV, Eddings W. A note on how to perform multipleimputation diagnostics in Stata. 2011. Accessed at www.stata.com /users/ymarchenko/midiagnote.pdf on 25 March 2016.
39. Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE, Sandbæk A, et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): A cluster-randomised trial. Lancet. 2011;378:156-67. [PMID: 21705063] doi:10.1016 /S0140-6736(11)60698-3
40. Bittner V, Bertolet M, Barraza Felix R, Farkouh ME, Goldberg S, Ramanathan KB, et al; BARI 2D Study Group. Comprehensive cardiovascular risk factor control improves survival: The BARI 2D trial. J Am Coll Cardiol. 2015;66:765-73. [PMID: 26271057] doi:10.1016/j .jacc.2015.06.019
41. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G; Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord. 2000;24 Suppl 3:S6-11. [PMID: 11063279]
42. Sandbæk A, Griffin SJ, Sharp SJ, Simmons RK, Borch-Johnsen K, Rutten GE, et al. Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: A randomized controlled trial: The ADDITION-Europe Study. Diabetes Care. 2014;37:2015-23. [PMID: 24784827] doi:10.2337/dc13-1544
43. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003; 56:395-407. [PMID: 12812812]
44. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1-45. [PMID: 24222016] doi: 10.1161/01.cir.0000437738.63853.7a
45. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140-9. [PMID: 25538310] doi:10.2337/dc14-2441
46. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med. 2011;154:554-9. [PMID: 21502652] doi:10.7326/0003-4819-154-8-201104190-00007
47. Ali MK, Jaacks LM, Kowalski AJ, Siegel KR, Ezzati M. Noncommunicable diseases: three decades of global data show a mixture of increases and decreases in mortality rates. Health Aff (Millwood). 2015;34:1444-55. [PMID: 26355045] doi:10.1377/hlthaff.2015.0570